• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体中的胰高血糖素代谢,对正常人和糖尿病患者胰高血糖素的代谢清除率及血浆急性消失时间的研究。

Glucagon metabolism in man, studies on the metabolic clearance rate and the plasma acute disappearance time of glucagon in normal and diabetic subjects.

作者信息

Alford F P, Bloom S R, Nabarro J D

出版信息

J Clin Endocrinol Metab. 1976 May;42(5):830-8. doi: 10.1210/jcem-42-5-830.

DOI:10.1210/jcem-42-5-830
PMID:773949
Abstract

To investigate further the "hyperglucagonaemia" of diabetes mellitus, the metabolic clearance rate (MCR) and acute disappearance time (t1/2) of unlabelled pancreatic glucagon were estimated in 9 normal subjects and 7 insulin-dependent diabetics, using a constant infusion technique. The mean MCR (+/-SE) was similar for both groups (control: 9.0 +/- 0.6; diabetics: 11.4 +/- 1.0 ml/kg/min). The MCR was not influenced by the concentration of glucagon at the time of plateau, and the exogenous hormone appeared to be handled similarly to endogenous glucagon. On the other hand, t1/2 calculated from the fractional decay rate of glucagon from plateau was significantly prolonged in the diabetics (t1/2 6.6 +/- 0.5 min) compared with the control group (t1/2 4.8 +/- 0.2 min, P less than 0.01). Furthermore, there was no correlation between MCR and t1/2, for the control, diabetic, or combined group. It therefore appears that the MCR of glucagon is similar in normal and diabetic subjects. However, since the acute disappearance time (t1/2) of glucagon is not identical in these two groups, it appears that the kinetics of the overall in vivo metabolism of pancreatic glucagon are not similar in diabetic and control subjects.

摘要

为了进一步研究糖尿病患者的“高胰高血糖素血症”,采用持续输注技术,对9名正常受试者和7名胰岛素依赖型糖尿病患者未标记的胰高血糖素的代谢清除率(MCR)和急性消失时间(t1/2)进行了评估。两组的平均MCR(±SE)相似(对照组:9.0±0.6;糖尿病患者:11.4±1.0ml/kg/min)。MCR不受平台期胰高血糖素浓度的影响,外源性激素的处理方式似乎与内源性胰高血糖素相似。另一方面,根据胰高血糖素从平台期的分数衰减率计算出的t1/2在糖尿病患者中显著延长(t1/2 6.6±0.5分钟),而对照组为(t1/2 4.8±0.2分钟,P<0.01)。此外,对照组、糖尿病组或合并组的MCR与t1/2之间均无相关性。因此,正常受试者和糖尿病患者中胰高血糖素的MCR似乎相似。然而,由于这两组中胰高血糖素的急性消失时间(t1/2)并不相同,糖尿病患者和对照组中胰高血糖素整体体内代谢的动力学似乎并不相似。

相似文献

1
Glucagon metabolism in man, studies on the metabolic clearance rate and the plasma acute disappearance time of glucagon in normal and diabetic subjects.人体中的胰高血糖素代谢,对正常人和糖尿病患者胰高血糖素的代谢清除率及血浆急性消失时间的研究。
J Clin Endocrinol Metab. 1976 May;42(5):830-8. doi: 10.1210/jcem-42-5-830.
2
Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.间歇性内源性高胰高血糖素血症对正常人和糖尿病患者葡萄糖稳态的影响。
J Clin Invest. 1979 Jun;63(6):1119-23. doi: 10.1172/JCI109404.
3
Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin.非酮症糖尿病患者和正常受试者血浆胰岛素消失的动力学分析。一项使用125I胰岛素的示踪研究。
J Clin Invest. 1978 Jan;61(1):197-208. doi: 10.1172/JCI108918.
4
Kinetics of human connecting peptide in normal and diabetic subjects.正常人和糖尿病患者体内人连接肽的动力学
J Clin Invest. 1978 Jul;62(1):197-203. doi: 10.1172/JCI109106.
5
Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men.胰高血糖素对正常男性和糖尿病男性内脏净环磷酸腺苷生成的影响。
J Clin Invest. 1974 Jan;53(1):198-204. doi: 10.1172/JCI107538.
6
Metabolic clearance and production rates of human growth hormone.
J Clin Invest. 1969 Dec;48(12):2349-58. doi: 10.1172/JCI106201.
7
Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.胰岛素 - 葡萄糖输注对空腹糖尿病患者和非糖尿病患者血浆胰高血糖素水平的影响。
J Clin Invest. 1975 Nov;56(5):1132-8. doi: 10.1172/JCI108188.
8
Growth hormone kinetics in diabetic patients.
Diabetes. 1975 Apr;24(4):317-27. doi: 10.2337/diab.24.4.317.
9
Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.正常和胰岛素依赖型糖尿病患者中血浆葡萄糖和游离脂肪酸水平升高对胰高血糖素分泌抑制作用的比较。糖尿病中α细胞对葡萄糖选择性不敏感的证据。
J Clin Invest. 1976 Aug;58(2):320-5. doi: 10.1172/JCI108475.
10
Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.尿毒症和血液透析对胰高血糖素周转及代谢效应的影响。
J Clin Invest. 1976 Mar;57(3):722-31. doi: 10.1172/JCI108330.

引用本文的文献

1
Splanchnic and Leg Glucagon Metabolism in Healthy Individuals and Those With Type 1 Diabetes: First-in-Human Study Using [13C9,15N1]Glucagon.健康个体及1型糖尿病患者的内脏和腿部胰高血糖素代谢:使用[13C9,15N1]胰高血糖素的首次人体研究。
Diabetes. 2025 Aug 1;74(8):1342-1354. doi: 10.2337/db24-1064.
2
GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic β-cell function in obese male mice.胰高血糖素样肽-1受体/胰高血糖素受体双重激动作用可消除肥胖雄性小鼠的肝脂肪变性,恢复胰岛素敏感性并挽救胰腺β细胞功能。
Nat Commun. 2025 May 21;16(1):4714. doi: 10.1038/s41467-025-59773-4.
3
Nonlinear Mixed Effects Modeling of Glucagon Kinetics in Healthy Subjects.
健康受试者胰高血糖素动力学的非线性混合效应模型。
IEEE Trans Biomed Eng. 2023 Sep;70(9):2733-2740. doi: 10.1109/TBME.2023.3262974. Epub 2023 Aug 30.
4
A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment.等血糖静脉葡萄糖输注实验的葡萄糖-胰岛素-胰高血糖素耦合模型。
Front Physiol. 2022 Sep 6;13:911616. doi: 10.3389/fphys.2022.911616. eCollection 2022.
5
CN: glucagon-based novel isotope dilution mass spectrometry method for measurement of glucagon metabolism in humans.中文:基于胰高血糖素的新型同位素稀释质谱法用于测定人体胰高血糖素代谢。
Clin Proteomics. 2022 May 19;19(1):16. doi: 10.1186/s12014-022-09344-2.
6
A novel fast-slow model of diabetes progression: Insights into mechanisms of response to the interventions in the Diabetes Prevention Program.一种新的糖尿病进展的快慢模型:对糖尿病预防计划干预措施反应机制的深入了解。
PLoS One. 2019 Oct 10;14(10):e0222833. doi: 10.1371/journal.pone.0222833. eCollection 2019.
7
Proportional Insulin Infusion in Closed-Loop Control of Blood Glucose.血糖闭环控制中的比例胰岛素输注
PLoS One. 2017 Jan 6;12(1):e0169135. doi: 10.1371/journal.pone.0169135. eCollection 2017.
8
Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments.1型糖尿病中胰高血糖素的敏感性和清除率:来自体内和计算机模拟实验的见解
Am J Physiol Endocrinol Metab. 2015 Sep 1;309(5):E474-86. doi: 10.1152/ajpendo.00236.2015. Epub 2015 Jul 7.
9
Pharmacokinetics of insulin aspart and glucagon in type 1 diabetes during closed-loop operation.1型糖尿病患者闭环操作期间门冬胰岛素和胰高血糖素的药代动力学
J Diabetes Sci Technol. 2013 Nov 1;7(6):1507-12. doi: 10.1177/193229681300700610.
10
Pharmacokinetics modeling of exogenous glucagon in type 1 diabetes mellitus patients.1 型糖尿病患者外源性胰高血糖素的药代动力学建模。
Diabetes Technol Ther. 2013 Nov;15(11):935-41. doi: 10.1089/dia.2013.0150. Epub 2013 Aug 26.